In our cohort, however, the decline of circulating irisin from PreDM to T2DM, together with its weak association with insulin resistance indices, points toward reduced myokine production rather than compensatory hypersecretion—potentially reflecting impaired PGC-1α activation and skeletal muscle mitochondrial dysfunction. This evidence concerns the gene PPARGC1A and type 2 diabetes mellitus.